T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 601–650 of 1,103 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04973527	LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor	terminated	Phase 1	9	Beijing Boren HospitalOTHER	1	Aug 16, 2022	clinicaltrials
NCT05495100	A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma	unknown	Phase 2	45	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Aug 10, 2022